BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
©The Author(s) 2026.
World J Gastroenterol. Feb 7, 2026; 32(5): 113505
Published online Feb 7, 2026. doi: 10.3748/wjg.v32.i5.113505
Figure 2
Figure 2 Receiver operating characteristic curves for mucosal healing, C-reactive protein normalization, combined endpoint and antidrug antibody status. A: Mucosal healing; B: C-reactive protein; C: Composite endpoint; D: Antidrug antibody.


Write to the Help Desk